{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:24:34Z","timestamp":1794695074137,"version":"4.9.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To estimate fatal and nonfatal opioid overdose events in pregnant and postpartum women in Massachusetts, comparing rates in individuals receiving and not receiving pharmacotherapy for opioid use disorder (OUD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We conducted a population-based retrospective cohort study using linked administrative and vital statistics databases in Massachusetts to identify women with evidence of OUD who delivered a liveborn neonate in 2012\u20132014. We described maternal sociodemographic, medical, and substance use characteristics, computed rates of opioid overdose events in the year before and after delivery, and compared overdose rates by receipt of pharmacotherapy with methadone or buprenorphine in the prenatal and postpartum periods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Among 177,876 unique deliveries, 4,154 (2.3%) were to women with evidence of OUD in the year before delivery, who experienced 242 total opioid-related overdose events (231 nonfatal, 11 fatal) in the year before or after delivery. The overall overdose rate was 8.0 per 100,000 person-days. Overdoses were lowest in the third trimester (3.3\/100,000 person-days in the third trimester) and then increased in the postpartum period with the highest overdose rate 7\u201312 months after delivery (12.3\/100,000 person-days). Overall, 64.3% of women with evidence of OUD in the year before delivery received any pharmacotherapy in the year before delivery. Women receiving pharmacotherapy had reduced overdose rates in the early postpartum period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Pregnant women in Massachusetts have high rates of OUD. The year after delivery is a vulnerable period for women with OUD. Additional longitudinal supports and interventions tailored to women in the first year postpartum are needed to prevent and reduce overdose events.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000002734","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T15:35:16Z","timestamp":1531323316000},"page":"466-474","source":"Crossref","is-referenced-by-count":323,"title":["Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts"],"prefix":"10.1097","volume":"132","author":[{"given":"Davida M.","family":"Schiff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishka","family":"Terplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malena","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Bernson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsatou","family":"Diop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bharel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Wilens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"LaRochelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Y.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231015","doi-asserted-by":"crossref","first-page":"897","DOI":"10.15585\/mmwr.mm6634a2","article-title":"Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region\u2014United States, 2006\u20132015","volume":"66","author":"O'Donnell","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-20231015","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-20231015","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in Drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-20231015","first-page":"161","article-title":"Drug-induced deaths\u2014United States, 1999\u20132010","volume":"62","author":"Mack","year":"2013","journal-title":"MMWR Suppl"},{"key":"R5-20231015","first-page":"719","article-title":"Vital signs: demographic, use substance. trends among heroin users\u2014United States, 2002-2013","volume":"64","author":"Jones","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R6-20231015","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"R9-20231015","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/AOG.0000000000001695","article-title":"Maternal deaths from suicide and overdose in Colorado, 2004-2012","volume":"128","author":"Metz","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R10-20231015","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"key":"R11-20231015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.drugalcdep.2017.01.003","article-title":"Non-medical opioid use and sources of opioids among pregnant and non-pregnant reproductive-aged women","volume":"174","author":"Kozhimannil","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"R12-20231015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11920-015-0626-5","article-title":"Substance use in the perinatal period","volume":"17","author":"Forray","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"R13-20231015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2015.02.027","article-title":"Perinatal substance use: a prospective evaluation of abstinence and relapse","volume":"150","author":"Forray","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R14-20231015","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R15-20231015","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jogc.2017.04.028","article-title":"No. 349\u2014Substance use in pregnancy","volume":"39","author":"Ordean","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"R16-20231015","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/add.13462","article-title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child","volume":"111","author":"Zedler","year":"2016","journal-title":"Addiction"},{"key":"R18-20231015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.drugalcdep.2015.02.012","article-title":"Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder","volume":"149","author":"Wilder","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R19-20231015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/ADM.0b013e318229bb25","article-title":"Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction","volume":"6","author":"Peles","year":"2012","journal-title":"J Addict Med"},{"issue":"suppl","key":"R28-20231015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1360-0443.2012.04041.x","article-title":"Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes","volume":"107","author":"Benningfield","year":"2012","journal-title":"Addiction"},{"key":"R29-20231015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ADM.0000000000000308","article-title":"Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: literature review to support national guidance","volume":"11","author":"Klaman","year":"2017","journal-title":"J Addict Med"},{"key":"R30-20231015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jsat.2014.04.004","article-title":"Postpartum changes in methadone maintenance dose","volume":"47","author":"Pace","year":"2014","journal-title":"J Subst Abuse Treat"},{"key":"R31-20231015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/03630242.2013.804025","article-title":"Postpartum substance use and depressive symptoms: a review","volume":"53","author":"Chapman","year":"2013","journal-title":"Women Health"},{"key":"R32-20231015","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"R33-20231015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of fentanyl overdose\u2014Massachusetts, 2014\u20132016","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201808000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T04:01:52Z","timestamp":1697342512000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201808000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002734","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}